International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC – Marketwired (press release)
|
International Stem Cell Corporation Announces Commencement of Enrollment of Phase I Trial of ISC-hpNSC
Marketwired (press release) CARLSBAD, CA–(Marketwired – March 07, 2016) – International Stem Cell Corporation ( OTCQB : ISCO), a clinical stage biotechnology company developing novel stem cell-based therapies, announced today that it is enrolling patients in the Phase I trial of … |
